Democrats in Congress are slamming the Supreme Court's ruling in the birthright citizenship case. Our next guest, Democratic Congressman Jamie Raskin, wrote on X, "Eager to sue Trump's wounded ego, the Supreme Court ended nationwide injunctions. Trump is crowing, but this is this just means we'll take our smashing wins in four district courts and turn them into wins in 94 district courts. People born here are citizens, period." Ranking member on the House Judiciary Committee, Congressman Jamie Rascin joins ...

LOS ANGELES, June 24, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quipt Home Medical Corp. ("Quipt" or "the Company") (NASDAQ: QIPT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. One of Quipt's largest shareholders, Forager Capital Management ("Forager" ...

LOS ANGELES, June 11, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bausch + Lomb Corporation ("Bausch + Lomb" or "the Company") (NYSE: BLCO) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Bausch + Lomb reported its financial results for Q1 2025 on April 30 ...

LOS ANGELES, May 8, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE: SLQT) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. SelectQuote is the subject of a DOJ False Claims Act filed on May 1, 2025. The f ...

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. ICU Medical is the subject of an FDA warning letter published on April 22, 2025. According to the government agency, the Company "made multiple changes to the Medfusion Model 4000 Syringe Infusion Pump and CADD Solis VIP Ambulatory Infusion Pump that could significantly affect the safety or effectiveness of these devices." The FDA states that the Company's ...